Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.5.0.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Oct. 31, 2016
Oct. 31, 2015
Cash flows from operating activities:    
Net loss $ (43,873) $ (25,417)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization of property and equipment 2,289 2,554
Provision for loss contract   9,162
Provision for inventory obsolescence 318 65
Amortization of intangible assets 2,519 3,560
Fair value of acquisition-related contingent consideration 249 1,475
Stock-based compensation expense 1,816 3,004
Deferred income taxes 14,649 (960)
Other 113 61
Changes in operating assets and liabilities, excluding impact of acquisition:    
Accounts receivable 1,987 895
Unbilled receivables 2,913 (5,743)
Inventories 338 (1,207)
Prepaid expenses and other assets 428 (158)
Accounts payable (2,102) 718
Accrued expenses (4,942) (4,056)
Deferred revenues (3,864) (2,770)
Other 173 (625)
Total cash used in operating activities (26,989) (19,442)
Cash flows from investing activities:    
Purchases of property and equipment (521) (1,140)
Investment in capitalized software   (2,030)
Purchases of marketable securities (2,252) (3,005)
Proceeds from sale and maturity of marketable securities 4,249 4,503
Cash paid for acquisition of business, net of cash acquired (5,243) (11,686)
Other investing activities 2 453
Total cash used in investing activities (3,765) (12,905)
Cash flows from financing activities:    
Proceeds from issuance of common stock 64 88
Other financing activities (4)  
Total cash provided by financing activities 60 88
Effect of exchange rate changes on cash (555) 270
Net decrease in cash and cash equivalents (31,249) (31,989)
Cash and cash equivalents, beginning of period 58,733 90,019
Cash and cash equivalents, end of period 27,484 58,030
Supplemental disclosure of cash flow information:    
Income taxes paid 120 495
Supplemental disclosure of non-cash investing and financing activities:    
Asset group classified as held for sale 235  
Transfer of items originally classified as inventories to equipment 24 342
DCC Labs [Member]    
Supplemental disclosure of non-cash investing and financing activities:    
Fair value of common stock issued for acquisition 2,640  
Timeline Labs [Member]    
Supplemental disclosure of non-cash investing and financing activities:    
Fair value of common stock issued for acquisition   3,025
Common Stock [Member]    
Supplemental disclosure of non-cash investing and financing activities:    
Fair value of common stock issued for deferred stock consideration obligation $ 3,454 $ 1,753